Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Entera Bio Ltd. (ENTX) had Consolidated Net Income/Loss of $-2.66M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$2.67M |
|
$-2.67M |
|
$0.01M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
|
Consolidated Net Income/Loss |
$-2.66M |
$-2.66M |
|
$-2.67M |
|
$-2.66M |
|
46.84M |
|
46.84M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$19.31M |
|
$0.08M |
|
$0.36M |
|
$19.67M |
|
$1.84M |
|
-- |
|
$0.57M |
|
$2.41M |
|
$17.26M |
|
$17.26M |
|
$17.26M |
|
45.45M |
|
| Cash Flow Statement Financials | |
$-3.04M |
|
$-0.04M |
|
$13.29M |
|
$8.74M |
|
$18.95M |
|
$10.21M |
|
$1.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.39% |
|
-15.39% |
|
-13.50% |
|
-15.39% |
|
$0.38 |
|
$-0.07 |
|
$-0.06 |
|